JANX logo

Janux Therapeutics, Inc. (JANX) Cash From Investing

Annual CFI:

-$258.02M-$216.83M(-526.36%)
December 31, 2024

Summary

  • As of today, JANX annual cash from investing is -$258.02 million, with the most recent change of -$216.83 million (-526.36%) on December 31, 2024.
  • During the last 3 years, JANX annual cash from investing has risen by +$82.94 million (+24.33%).
  • JANX annual cash from investing is now -542.83% below its all-time high of $58.27 million, reached on December 31, 2022.

Performance

JANX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

Quarterly CFI:

$1.56M+$341.95M(+100.46%)
June 30, 2025

Summary

  • As of today, JANX quarterly cash from investing is $1.56 million, with the most recent change of +$341.95 million (+100.46%) on June 30, 2025.
  • Over the past year, JANX quarterly cash from investing has increased by +$192.45 million (+100.82%).
  • JANX quarterly cash from investing is now -95.40% below its all-time high of $33.93 million, reached on December 31, 2024.

Performance

JANX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

TTM CFI:

-$292.23M+$192.45M(+39.71%)
June 30, 2025

Summary

  • As of today, JANX TTM cash from investing is -$292.23 million, with the most recent change of +$192.45 million (+39.71%) on June 30, 2025.
  • Over the past year, JANX TTM cash from investing has increased by +$62.72 million (+17.67%).
  • JANX TTM cash from investing is now -534.89% below its all-time high of $67.20 million, reached on September 30, 2022.

Performance

JANX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJANXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

JANX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-526.4%+100.8%+17.7%
3Y3 Years+24.3%-82.7%-84.8%
5Y5 Years-100.0%+100.0%-100.0%

JANX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-542.8%+24.3%-95.4%+100.5%-534.9%+39.7%
5Y5-Year-542.8%+24.3%-95.4%+100.5%-534.9%+39.7%
All-TimeAll-Time-542.8%+24.3%-95.4%+100.5%-534.9%+39.7%

JANX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$1.56M(+100.5%)
-$292.23M(+39.7%)
Mar 2025
-
-$340.39M(-1103.3%)
-$484.68M(-87.8%)
Dec 2024
-$258.02M(-526.4%)
$33.93M(+167.7%)
-$258.02M(+8.1%)
Sep 2024
-
$12.67M(+106.6%)
-$280.82M(+20.9%)
Jun 2024
-
-$190.88M(-67.8%)
-$354.95M(-142.8%)
Mar 2024
-
-$113.74M(-1122.5%)
-$146.19M(-254.9%)
Dec 2023
-$41.19M(-170.7%)
$11.12M(+118.1%)
-$41.19M(+23.6%)
Sep 2023
-
-$61.45M(-443.8%)
-$53.92M(-297.6%)
Jun 2023
-
$17.87M(+304.5%)
$27.29M(+47.9%)
Mar 2023
-
-$8.74M(-444.9%)
$18.46M(-68.3%)
Dec 2022
$58.27M
-$1.60M(-108.1%)
$58.27M(-13.3%)
DateAnnualQuarterlyTTM
Sep 2022
-
$19.76M(+118.6%)
$67.20M(+142.5%)
Jun 2022
-
$9.04M(-70.9%)
-$158.11M(+49.0%)
Mar 2022
-
$31.07M(+324.1%)
-$309.74M(+9.2%)
Dec 2021
-$340.96M(>-9900.0%)
$7.33M(+103.6%)
-$340.96M(+2.1%)
Sep 2021
-
-$205.54M(-44.1%)
-$348.29M(-144.0%)
Jun 2021
-
-$142.60M(>-9900.0%)
-$142.75M(>-9900.0%)
Mar 2021
-
-$153.00K(>-9900.0%)
-$153.00K(>-9900.0%)
Dec 2020
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2020
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2020
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00
$0.00
Dec 2019
$0.00
-
-

FAQ

  • What is Janux Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Janux Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Janux Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Janux Therapeutics, Inc.?
  • What is Janux Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Janux Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of JANX is -$258.02M

What is the all-time high annual cash from investing for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high annual cash from investing is $58.27M

What is Janux Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, JANX annual cash from investing has changed by -$216.83M (-526.36%)

What is Janux Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of JANX is $1.56M

What is the all-time high quarterly cash from investing for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high quarterly cash from investing is $33.93M

What is Janux Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, JANX quarterly cash from investing has changed by +$192.45M (+100.82%)

What is Janux Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of JANX is -$292.23M

What is the all-time high TTM cash from investing for Janux Therapeutics, Inc.?

Janux Therapeutics, Inc. all-time high TTM cash from investing is $67.20M

What is Janux Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, JANX TTM cash from investing has changed by +$62.72M (+17.67%)
On this page